- GlobeNewswire•6 days ago
ZIOPHARM Oncology to Host First-Quarter 2017 Financial Results and Corporate Update Conference Call on May 1, 2017 at 4:30 p.m. ET
BOSTON, April 24, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will host a conference call and webcast slide presentation on Monday, ...
- Accesswire•9 days ago
NEW YORK, NY / ACCESSWIRE / April 21, 2017 / The Biotech Industry posted better gains this year as the "price gouging" concerns, which were a major problem for the industry in 2016, appears to ...
- GlobeNewswire•10 days ago
ZIOPHARM Oncology to Present Updated Clinical Results of Gene Therapy Candidate Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting
BOSTON, April 20, 2017-- ZIOPHARM Oncology, Inc., a biopharmaceutical company focused on new immunotherapies, today announced that it will present updated results from its Phase 1, multicenter, dose-escalation ...
ZIOP : Summary for ZIOPHARM Oncology Inc - Yahoo Finance
ZIOPHARM Oncology, Inc. (ZIOP)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.91 x 100|
|Ask||8.50 x 600|
|Day's Range||6.90 - 7.61|
|52 Week Range||4.45 - 8.72|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|